Antibody Classes

Why This Matters

Antibody classes represent one of the most elegant examples of structural specialization in the immune system. You're being tested on how the same basic Y-shaped protein can be modified to perform radically different functions—from crossing the placenta to triggering allergic reactions to guarding mucosal surfaces. The five classes (IgG, IgM, IgA, IgE, IgD) demonstrate key immunological principles: primary vs. secondary immune responses, mucosal immunity, complement activation, and hypersensitivity reactions.

Don't just memorize which antibody is "most abundant" or "found in breast milk." Know why each class evolved its particular structure and location. When an FRQ asks about neonatal immunity, you need to connect IgG's placental transfer to IgA's presence in breast milk—both solving the same problem (protecting immunologically naive infants) through different mechanisms.

---

Primary vs. Secondary Response Antibodies

The immune system produces different antibody classes depending on timing. IgM appears first as a rapid-response molecule, while IgG dominates the longer-lasting secondary response.

IgM

• First antibody produced during an infection—its presence indicates acute or recent exposure to a pathogen
• Pentameric structure (five Y-shaped units joined together) creates 10 antigen-binding sites, compensating for lower individual binding affinity
• Strongest complement activator among all antibody classes, triggering the classical pathway for rapid pathogen destruction

IgG

• Most abundant serum antibody (75-80% of circulating immunoglobulins), representing the mature, high-affinity response after class switching
• Crosses the placenta via FcRn receptors, providing passive immunity to the fetus during the third trimester
• Primary opsonin that enhances phagocytosis by coating pathogens and binding Fc receptors on macrophages and neutrophils

---

Mucosal and Secretory Immunity

Not all immune battles happen in the bloodstream. IgA specializes in defending epithelial surfaces where pathogens first contact the body.

IgA

• Dominant antibody at mucosal surfaces—gut, respiratory tract, saliva, tears, and breast milk form the first line of adaptive defense
• Dimeric structure (two units joined by a J chain and secretory component) resists enzymatic degradation in harsh mucosal environments
• Immune exclusion function neutralizes pathogens and toxins before they penetrate epithelial barriers, preventing infection rather than fighting it

---

Hypersensitivity and Parasitic Defense

Some antibody classes trigger inflammatory responses rather than directly neutralizing pathogens. IgE's ability to activate mast cells makes it essential for anti-parasitic immunity but problematic in allergic disease.

IgE

• Lowest serum concentration of any antibody class, but extremely potent due to high-affinity binding to FcεRI receptors on mast cells and basophils
• Triggers Type I hypersensitivity when crosslinked by allergens, causing mast cell degranulation and histamine release within minutes
• Anti-helminth defense activates eosinophils to destroy parasitic worms too large for phagocytosis—an evolutionary trade-off that now causes allergies

---

B Cell Receptor Function

Before antibodies are secreted, they exist as membrane-bound receptors that help activate B cells. IgM and IgD serve as the primary B cell receptors (BCRs) on naive B cells.

IgD

• Co-expressed with IgM on mature naive B cells, functioning as a membrane-bound antigen receptor rather than a secreted antibody
• Role in B cell activation—engagement of surface IgD contributes to initiating the adaptive immune response upon first antigen encounter
• Poorly understood secreted function—found at low serum levels with possible roles in respiratory immunity and basophil activation

---

Quick Reference Table

---

Self-Check Questions

1. A patient's serum shows high IgM but low IgG against a specific pathogen. What does this indicate about the timing of infection, and what immunological process hasn't yet occurred?

2. Which two antibody classes provide passive immunity to newborns, and how do their delivery routes and protective locations differ?

3. Compare IgE's role in allergic reactions versus parasitic infections—why might the same mechanism be beneficial in one context and harmful in another?

4. If you were designing a mucosal vaccine (nasal spray), which antibody class would you want to stimulate, and what structural feature makes it suited for this environment?

5. An FRQ asks you to explain why IgM is effective despite having lower binding affinity than IgG. What structural adaptation compensates for this, and how does it enhance function?